Accéder au contenu
Merck
  • Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.

Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.

Bioorganic & medicinal chemistry letters (2004-05-06)
Akihiko Tanitame, Yoshihiro Oyamada, Keiko Ofuji, Yoko Kyoya, Kenji Suzuki, Hideaki Ito, Motoji Kawasaki, Kazuo Nagai, Masaaki Wachi, Jun-ichi Yamagishi
RÉSUMÉ

In this study, we report the design, synthesis and structure-activity relationships of novel indazole derivatives as DNA gyrase inhibitors with Gram-positive antibacterial activity. Our results show that selected compounds from this series exhibit potent antibacterial activity against Gram-positive bacteria including multi-drug resistant strains that is methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1-Boc-piperazine, 97%